Optimal whole blood dilution protocol for preprocessing samples prior to circulating tumor cell capture by size-based isolation

被引:0
|
作者
Fu, Tianhao [1 ]
Li, Sheng [2 ,3 ,4 ]
Wei, Liang [5 ]
Huang, Shaoyi [5 ]
Xue, Yan [6 ]
Cui, Kai [2 ,3 ,4 ]
机构
[1] Guangxi Med Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, Nanning, Peoples R China
[2] Shandong Univ, Shandong Canc Hosp, Cheeloo Coll Med, Dept Hepatobiliary Surg, Jinan, Peoples R China
[3] Shandong First Med Univ, Jinan, Peoples R China
[4] Shandong Acad Med Sci, Jinan, Peoples R China
[5] Wuhan YZY Med Sci & Technol Co Ltd, Wuhan, Peoples R China
[6] Jinan Childrens Hosp, Jinan, Peoples R China
关键词
blood dilution; circulating tumor cell; circulating tumor microemboli; size-based isolation;
D O I
10.1002/jcla.24524
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background This study compared whole blood dilution versus density gradient centrifugation for pre-processing blood samples prior to circulating tumor cell (CTC) capture on the efficiency of CTC separation by size-based isolation. Materials and methods Whole blood from a healthy volunteer spiked with SKBR3 cells was used to optimize the whole blood dilution protocol for sample volume, dilution ratio, and paraformaldehyde (PFA) concentration. Whole blood from healthy volunteers spiked with SKBR3, A549, or PC3 cells, and whole blood from patients with advanced gastric, esophageal, or liver cancer, was used to compare pre-processing by the optimal whole blood dilution protocol with density-gradient centrifugation. All statistical evaluations were performed using Student t test of the Statistical Package for Social Sciences (SPSS version 17.0). Results In blood samples from healthy volunteers, spiked SKBR3 cell recovery rates were highest in 5 ml of whole blood, diluted with 2.5 ml buffer, and fixed with 0.2% PFA, and spiked SKBR3, A549, and PC3 cell recovery rates from 5 ml whole blood were significantly greater when using the optimized whole blood dilution protocol (87.67% +/- 1.76%, 79.50% +/- 0.50% and 71.83% +/- 1.04%, respectively) compared to density-gradient centrifugation (46.83 +/- 1.76%, 37.00 +/- 1.50% and 41.00 +/- 1.50%, respectively).
引用
收藏
页数:6
相关论文
共 43 条
  • [1] Size-based isolation of circulating tumor cells (CTCs) in mouse tumor models
    Kolostova, Katarina
    Hoffman, Robert M.
    Maawy, Ali
    Zhang, Yong
    Bobek, Vladimir
    CANCER RESEARCH, 2014, 74 (19)
  • [2] Clinical Validation of a Size-Based Microfluidic Device for Circulating Tumor Cell Isolation and Analysis in Renal Cell Carcinoma
    Leitao, Tito Palmela
    Corredeira, Patricia
    Kucharczak, Sandra
    Rodrigues, Margarida
    Piairo, Paulina
    Rodrigues, Carolina
    Alves, Patricia
    Cavaco, Ana Martins
    Miranda, Miguel
    Antunes, Marilia
    Ferreira, Joao
    Palma Reis, Jose
    Lopes, Tome
    Dieguez, Lorena
    Costa, Luis
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (09)
  • [3] Size-based isolation and detection of renal carcinoma cells from whole blood
    De Alwis, Roger
    Hansson, Jennifer
    Lindgren, David
    Schoch, Sarah
    Tejera, Alexander
    Scholtz, Bianca
    Elfving, Peter
    Moeller, Christina
    Nilsson, Helen
    Johansson, Martin
    Axelson, Hakan
    MOLECULAR AND CLINICAL ONCOLOGY, 2022, 16 (05)
  • [4] Size-based detection of sarcoma circulating tumor cells and cell clusters
    Hayashi, Masanori
    Zhu, Peixuan
    McCarty, Gregory
    Meyer, Christian F.
    Pratilas, Christine A.
    Levin, Adam
    Morris, Carol D.
    Albert, Catherine M.
    Jackson, Kyle W.
    Tang, Cha-Mei
    Loeb, David M.
    ONCOTARGET, 2017, 8 (45) : 78965 - 78977
  • [5] A New Size-based Platform for Circulating Tumor Cell Detection in Colorectal Cancer Patients
    Oh, Bo Young
    Kim, Jhingook
    Lee, Woo Yong
    Kim, Hee Cheol
    CLINICAL COLORECTAL CANCER, 2017, 16 (03) : 214 - 219
  • [6] Heterogenous circulating tumor cells detected by a size-based method in the blood of breast cancer patients
    Nagai, Shigenori
    Sato, Motoi
    Tozuka, Katsunori
    Kobayashi, Yasuhito
    Inoue, Kenichi
    Suganuma, Masami
    CANCER SCIENCE, 2018, 109 : 522 - 522
  • [7] Size-Based Isolation of Circulating Tumor Cells in Lung Cancer Patients Using a Microcavity Array System
    Hosokawa, Masahito
    Kenmotsu, Hirotsugu
    Koh, Yasuhiro
    Yoshino, Tomoko
    Yoshikawa, Takayuki
    Naito, Tateaki
    Takahashi, Toshiaki
    Murakami, Haruyasu
    Nakamura, Yukiko
    Tsuya, Asuka
    Shukuya, Takehito
    Ono, Akira
    Akamatsu, Hiroaki
    Watanabe, Reiko
    Ono, Sachiyo
    Mori, Keita
    Kanbara, Hisashige
    Yamaguchi, Ken
    Tanaka, Tsuyoshi
    Matsunaga, Tadashi
    Yamamoto, Nobuyuki
    PLOS ONE, 2013, 8 (06):
  • [8] Development of an automated size-based filtration system for isolation of circulating tumor cells in lung cancer patients
    Yagi, Satomi
    Koh, Yasuhiro
    Akamatsu, Hiroaki
    Kanai, Kuninobu
    Hayata, Atsushi
    Tokudome, Nahomi
    Akamatsu, Keiichiro
    Endo, Katsuya
    Nakamura, Seita
    Higuchi, Masayuki
    Kanbara, Hisashige
    Nakanishi, Masanori
    Ueda, Hiroki
    Yamamoto, Nobuyuki
    PLOS ONE, 2017, 12 (06):
  • [9] Isolation and characterization of viable pancreatic cancer circulating tumor cells using size-based filtration system
    Yu, Kenneth H.
    Krempley, Benjamin D.
    McCarthy, Brian
    CANCER RESEARCH, 2017, 77
  • [10] Development of an automated device for size-based enrichment and isolation of circulating tumor cells in lung cancer patients
    Yagi, Satomi
    Koh, Yasuhiro
    Akamatsu, Hiroaki
    Kim, Woong
    Tanaka, Ayaka
    Kanai, Kuninobu
    Hayata, Atsushi
    Shibaki, Ryota
    Higuchi, Masayuki
    Kanbara, Hisashige
    Kikuchi, Takashi
    Akamatsu, Keiichiro
    Nakanishi, Masanori
    Ueda, Hiroki
    Yamamoto, Nobuyuki
    CANCER RESEARCH, 2016, 76